Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Shiro Ibe"'
Autor:
Fatemeh Jahanbakhsh, Junko Hattori, Masakazu Matsuda, Shiro Ibe, Seyed-Hamid R Monavari, Arash Memarnejadian, Mohammad R Aghasadeghi, Ehsan Mostafavi, Minoo Mohraz, Hossain Jabbari, Kianoush Kamali, Hossein Keyvani, Kayhan Azadmanesh, Wataru Sugiura
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e61864 (2013)
ObjectiveDrug-resistant (DR) HIV emerges during combined antiretroviral treatment (cART), creating concern about widespread transmission of DR-HIV as cART is expanded in resource-limited countries. The aim of this study was to determine the predomina
Externí odkaz:
https://doaj.org/article/60c3629b7fe94aae8b6a18e002068b59
Autor:
Nicholas I Nii-Trebi, Shiro Ibe, Jacob S Barnor, Koichi Ishikawa, James A M Brandful, Sampson B Ofori, Shoji Yamaoka, William K Ampofo, Wataru Sugiura
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e71972 (2013)
BACKGROUND: Limited HIV-1 drug-resistance surveillance has been carried out in Ghana since the implementation of antiretroviral therapy (ART). This study sought to provide data on the profile of HIV-1 drug resistance in ART-experienced and newly diag
Externí odkaz:
https://doaj.org/article/b310f75d656c464c81fd3b4850cbbf90
Autor:
Tadashi Miyamoto, Emi E Nakayama, Masaru Yokoyama, Shiro Ibe, Shunpei Takehara, Ken Kono, Yoshiyuki Yokomaku, Massimo Pizzato, Jeremy Luban, Wataru Sugiura, Hironori Sato, Tatsuo Shioda
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e47757 (2012)
Human immunodeficiency virus (HIV) type 2 shows limited geographical distribution compared with HIV type 1. Although 8 genetic groups of HIV type 2 (HIV-2) have been described, recombinant viruses between these groups are rarely observed. Recently, t
Externí odkaz:
https://doaj.org/article/664fe3d564884e3e858f1d9e41d50e28
Autor:
Masato Ito, Junko Hattori, Daisuke Shichi, Mayumi Imahashi, Atsushi Kawabata, Nobumasa Okumura, Chieko Hashiba, Kunio Yano, Masashi Nakahata, Kazuhisa Yoshimura, Haruki Taniguchi, Yasumasa Iwatani, Wataru Sugiura, Urara Shigemi, Masakazu Matsuda, Reiko Okazaki, Mai Kubota, Ayumi Kogure, Shiro Ibe, Hanako Kurai, Hisashi Tsurumi, Atsuko Hachiya, Takeshi Ikegaya, Takeshi Matsumoto, Yoshiyuki Yokomaku
Publikováno v:
Kansenshogaku Zasshi. 93:298-305
Autor:
Urara Shigemi, Yoshimi Yamamura, Masakazu Matsuda, Reiko Okazaki, Mai Kubota, Shiro Ibe, Michiko Nemoto, Masami Maejima-Kitagawa, Sayaka Sukegawa, Mayumi Imahashi, Tadashi Kikuchi, Wataru Sugiura, Yasumasa Iwatani, Atsuko Hachiya, Yoshiyuki Yokomaku
Publikováno v:
Journal of Clinical Virology. 152:105189
Although the number of HIV-2-infected individuals is quite low in Japan, at least three groups of HIV-2 (A, B and CRF01_AB) have been detected thus far. In particular, CRF01_AB HIV-2 cases have been found only in limited areas, Cote d'Ivoire and Japa
Clinical usefulness of multiplex PCR-lateral flow for the diagnosis of orthopedic-related infections
Autor:
Hiromi Kanda, Shiro Ibe, Shin Nihonyanagi, Katsufumi Uchiyama, Masaki Nakamura, Masashi Takaso, Yojiro Minegishi, Keizo Sakurai, Shinsuke Ikeda
Publikováno v:
Modern Rheumatology. 29:867-873
Objectives: Polymerase chain reaction (PCR)-based assays are being increasingly used for the diagnosis of orthopedic-related infections. Unfortunately, classical PCR requires imaging devices that are expensive and complex. We previously developed the
Autor:
Patrick Owiredu Bampoh, Kazuhisa Yoshimura, Tetsuro Matano, Koichi Ishikawa, William Ampofo, Jacob Samson Barnor, Wataru Sugiura, James Brandful, Nicholas Israel Nii-Trebi, Shoji Yamaoka, Shiro Ibe
Publikováno v:
Journal of Medical Microbiology. 66:1663-1672
Purpose. There have been hardly any reports on the human immunodeficiency virus type 1 (HIV-1) drug-resistance profile from northern Ghana since antiretroviral therapy (ART) was introduced over a decade ago. This study investigated prevailing HIV-1 s
Autor:
Osamu Hashimoto, Hitoshi Chiba, Shin Ichi Fujisawa, Junko Hattori, Wataru Sugiura, Shiro Ibe, Shingo Kato, Masakazu Matsuda, Kiyomi Okada, Yukumasa Kazuyama, Masashi Tatsumi, Shigeru Yoshida
Publikováno v:
AIDS Research and Human Retroviruses. 31:318-325
To design appropriate antiretroviral therapy regimens and avoid the emergence of human immunodeficiency virus (HIV)-1 variants with reduced susceptibility to antiretroviral drugs, genotypic drug-resistance testing (HIV genotyping) is strongly recomme
Autor:
Dai Watanabe1 dai@onh.go.jp, Shiro Ibe2, Tomoko Uehira1, Rumi Minami3, Atsushi Sasakawa1, Keishiro Yajima1, Hitoshi Yonemoto1, Hiroki Bando1, Yoshihiko Ogawa1, Tomohiro Taniguchi1, Daisuke Kasai1, Yasuharu Nishida1, Masahiro Yamamoto3, Tsuguhiro Kaneda4, Takuma Shirasaka1
Publikováno v:
BMC Infectious Diseases. 2011, Vol. 11 Issue 1, p146-154. 9p.
Autor:
Rumi Minami, Ichiro Koga, Shigeru Yoshida, Junko Hattori, Teiichiro Shiino, Hiroyuki Gatanaga, Yasuo Ota, Mami Nagashima, Ito Toshihiro, Haruyo Mori, Yoko Kojima, Masayasu Oie, Makiko Kondo, Dai Watanabe, Shingo Kato, Tsunefusa Hayashida, Shinichi Oka, Takuma Shirasaka, Masahiro Yamamoto, Atsuhisa Ueda, Satoru Sasaki, Mikio Ueda, Masakazu Matsuda, Shiro Ibe, Masao Tateyama, Yoshinari Tanabe, Jiro Fujita, Wataru Sugiura, Noboru Takata, Kenji Sadamasu, Yoshiaki Ishigatsubo, Takao Koike, Yoshiyuki Yokomaku
Publikováno v:
Antiviral Research. 88:72-79
The emergence and transmission of drug-resistant human immunodeficiency virus-1 (HIV-1) compromises antiretroviral treatment for HIV-1. Thus, testing for drug resistance is recommended at diagnosis and before initiating highly active antiretroviral t